Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion type Assertion NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_head.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion evidence source_evidence_literature NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion SIO_000772 20884628 NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion wasDerivedFrom befree-2016 NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion wasGeneratedBy ECO_0000203 NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.